bioRxivCell Biology
Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses
C. M. Failla, L. Capriotti, C. Scarponi, L. Mercurio, F. Facchiano, M. Morelli, S. Rossi, G. Pagnanelli, C. Albanesi, A. Cavani, S. Madonna
Abstract
In inflammatory skin conditions, such as psoriasis, vascular enlargement is associated with endothelial cell proliferation, release of cytokines and adhesion molecule expression. Interleukin (IL)-17A is a pro-inflammatory cytokine mainly secreted by T helper-17 cells that is critically involved in psoriasis pathogenesis. IL-36, IL-36{beta} and IL-36{gamma} are also inflammatory cytokines up-regulated in psoriasis and induced by various stimuli, including IL-17A. In this study, we found that human keratinocytes are the main source of IL-36, in particular of IL-36{gamma}. This cytokine was strongly induced by IL-17A and efficiently activated human dermal microvascular endothelial cells (HDMECs), which expressed both IL-17 and IL-36 receptors, by inducing a molecular signaling, such as phosphorylation of ERK1/2 and NF-{kappa}B P65 subunit. We highlighted the intense IL-17A- and IL-36{gamma}-dependent interplay between keratinocytes and HDMECs, likely active in the psoriatic lesions and leading to the establishment of a cytokine network responsible for the development and maintenance of the inflamed state. On HDMECs, IL-17A or IL-36{gamma} showed a synergic activity with TNF-, potently inducing inflammatory cytokine/chemokine release and ICAM-1 expression. We also investigated the involvement of IL-36{gamma} and VEGF-A, substantially reduced in lesional skin of psoriatic patients pharmacologically treated with the anti-IL-17A antibody Secukinumab. Importantly, keratinocyte-derived IL-36{gamma} represented an additional pro-angiogenic mediator of IL-17A. We observed that keratinocyte-derived VEGF-A influenced proliferation but not reduced inflammatory responses of HDMECs. On the other hand, inhibition of IL-36{gamma} released by IL-17A-treated keratinocytes impaired ICAM-1 expression in HDMECs. Taken together, our data demonstrated that IL-17A and IL-36{gamma} are highly involved in endothelial cells/keratinocytes crosstalk in inflammatory skin conditions.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CCR7+ Dendritic Cells Define a Type 17 Module in Psoriasis
Yang Sun, Fangzhou Lou, … Honglin Wang·Nature CommunicationsPeer-reviewed·Aug 15, 2025
- Modeling of the Network Mediated by IL-36 Involved inPsoriasis
Sneha Pandey, Syona Tiwari, … R. Pandey·bioRxiv·Jul 3, 2023
- Interleukin-36 promotes systemic Type-I IFN responses in severe psoriasis.
Marika Catapano, Marta Vergnano, … Francesca Capon·bioRxiv·Dec 14, 2018
- CD200R1 promotes IL-17 production by ILC3s, by enhancing STAT3 activation
H. Linley, A. Ogden, … A. Saunders·bioRxiv·Apr 17, 2022
- Pellino 1 Communicates Intercellular Signaling in Chronic Skin Inflammatory Microenvironment
Suhyeon Kim, Seoyoon Bae, … Chang-Woo Lee·bioRxiv·May 30, 2018
- Disease context dictates the cellular targets of IL-17 in inflammatory skin disease
Kellen J. Cavagnero, Fengwu Li, … Richard L. Gallo·Journal of Investigative DermatologyPeer-reviewed·Jul 1, 2026